TWO ARTICLES concerning drug resistance in patients from Mexico published in this issue of the ARCHIVES1,2 highlight key challenges to a global strategy for tuberculosis control.
Mexico has clearly reduced the tuberculosis problem from historically higher levels,3 evidenced by the character of the current epidemiological picture of the disease as primarily affecting older men and high-risk groups.2 Despite recommendations by international authorities, the policies implemented thus far appear limited and in need of revision if Mexico is to achieve success against tuberculosis. This is evidenced by the high proportion of the most highly infectious (smear-positive) patients who have already gone through the system without having been permanently cured, a relatively high level of resistance to the medications available for treatment, and the consequent negative impact on treatment results. Furthermore, the failure to implement a unified surveillance system for all tuberculosis cases in the country limits the ability of the government itself to detect the consequences of the inappropriate policies that are currently in place. Finally, and most importantly, much of this could have been avoided1 if the government had adopted or would fully adopt the recommendations of international scientific bodies4,5 for the treatment of tuberculosis patients.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.